Clinical Trial Posts on Medivizor
Navigation Menu

Clinical Trial Posts on Medivizor

Looking for patients with diabetes to try an education program with nutritional supplements to prevent retinal disease

Posted by on Oct 19, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is evaluating the impact of an education program plus nutritional supplements on the frequency of eye disease in patients with diabetes mellitus. The main outcome to be measured will be the changes in electroretinogram results, a lab test that measures vision quality. This study is recruiting in North Carolina. The...

Read More

Searching for patients with prostate cancer to test an experimental treatment before surgery

Posted by on Oct 3, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is investigating the effectiveness of pembrolizumab (Keytruda) plus enzalutamide (Xtandi) in patients with prostate cancer. The primary outcome to be measured will be the absence of cancer on the prostate after it is surgically removed. This study is being conducted in Portland, OR. The details...

Read More

Evaluating a triplet regimen for patients with relapsed or refractory MM after lenalidomide therapy

Posted by on Oct 1, 2019 in Multiple Myeloma | 0 comments

In a nutshell This study examined if PBD (pomalidomide, bortezomib, dexamethasone) was safe and effective in patients with multiple myeloma after lenalidomide (Revlimid) treatment. The authors concluded that pomalidomide improved survival without tumor growth or spread but increased side effects. Some background...

Read More

Looking for patients with relapsed or unresponsive multiple myeloma to try allogeneic CAR-T cell therapy

Posted by on Sep 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial is evaluating the safety and effectiveness of allogeneic CAR-T cell therapy (ALLO-715) in patients with multiple myeloma (MM) that has come back or stopped responding to treatment. The main outcome to be measured will be the number of patients who have side effects. This trial is recruiting in Denver, CO. The details Chimeric...

Read More

Looking for patients with poorly controlled type 2 diabetes to try the EndoBarrier System

Posted by on Sep 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is investigating the safety and effectiveness of the EndoBarrier system for patients with poorly controlled type 2 diabetes (T2D) and obesity. The main outcome to be measured will be the change in blood glucose levels. This trial is recruiting in multiple locations across the United States. The details Bariatric surgery is the...

Read More

Looking for participants with chronic stroke to test a device-assisted treatment

Posted by on Sep 30, 2019 in Stroke | 0 comments

In a nutshell This study is examining the effectiveness of a device-assisted practice of activities of daily living (ADL) to treat disability in stroke survivors. The main outcome to be measured will be the change in movement of the affected arm/hand. This study is being conducted in Illinois, US. The details A stroke happens when the blood flow to...

Read More

Searching for patients with advanced prostate cancer to test an experimental medication

Posted by on Sep 30, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 study will investigate the safety and effectiveness of AZD4635 in the treatment of metastatic castration-resistant prostate cancer (mCRPC). The main outcome will be the objective response rate (ORR) and prostate-specific antigen (PSA; a marker of prostate cancer) response. This trial is recruiting in multiple...

Read More

Looking for patients with hormone-receptor positive metastatic breast cancer to test an experimental biological drug

Posted by on Sep 30, 2019 in Breast cancer | 0 comments

In a nutshell This study is examining the effectiveness of biological drug sacituzumab govitecan (IMMU-132) compared to standard treatments for patients with hormone receptor-positive metastatic breast cancer. The main outcomes that will be measured are cancer responsiveness to the drug and survival of patients without the cancer growing. This trial...

Read More

Looking for patients with aggressive B-cell NHL to try an experimental combination treatment

Posted by on Sep 30, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study is investigating how well nivolumab (Opdivo) works with DA-REPOCH chemotherapy for treating aggressive B-cell non-Hodgkin's lymphoma (NHL). The primary outcome to be measured is 2-year survival without disease progression after treatment. This study is being conducted in Columbus, OH, in the United States. The...

Read More

Looking for patients with multiple myeloma to try a maintenance therapy combination after SCT

Posted by on Sep 30, 2019 in Multiple Myeloma | 0 comments

In a nutshell This trial will compare the effectiveness of two maintenance therapies in patients with multiple myeloma (MM) after a stem cell transplant (SCT). The main outcome to be measured will be the average time from treatment until death due to any cause.  The details Maintenance therapy is commonly given after SCT to help delay...

Read More

Looking for participants with advanced colorectal cancer to test a combination therapy

Posted by on Sep 25, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of standard therapy alone or combined with new drugs as first line treatment for advanced colorectal cancer. The main outcome to be measured will be safety and tumor response to the treatment.  The details Colorectal cancer is one of the most common cancers worldwide. A significant...

Read More